| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308509 | Seizure | 2013 | 5 Pages |
Abstract
In WHO grade II gliomas, Ki-67 is a molecular marker which predicts poor seizure control of glioma patients after the resection of the tumour. Gross-total resection, ki-67 overexpression and age below 38 years significantly affect seizure prognosis.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Yang Yuan, Wang Xiang, Liu Yanhui, Liang Ruofei, Liu Shuang, Fan Yingjun, Zhou Qiao, Yang Yanwu, Mao Qing,